- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05726435
Effects of Soluble Dietary Fiber on Sport Efficiency and Fatigue Delay in Top Basketball Players (FiberPlay)
Study Overview
Status
Intervention / Treatment
Detailed Description
Material, participants, methodology and research plan The material will be soluble fiber NUTRIOSE and placebo. Nutriose, derived from corn, is generally well tolerated and no allergic reactions are known. Participants will be made aware of this in informed consent. If, however, there will be any adverse reactions in participant, participant will withdraw from the study immediately.
The participants will be 14 adult, professional basketball players. The sample of subjects was determined by the size of the group in the same training process in order to exclude the influence of different training processes on the research results. Participants who have used antibiotics in the last 3 months, participants with type 1 and 2 diabetes, and also who have used other ergogenic aids in the last 30 days and still using them are excluded.
Participants will be randomly divided into two groups: the experimental group that will consume the tested fibers and the control group that will consume placebo. Design is a double-blind study where an independent statistician will be entrusted with the randomization of subjects into the two groups.
Sample variables:
Methods: dietary methods, anthropometric methods, fatigue assessment questionnaire and fecal samples analysis.
The sample of variables consists of: fecal sample for intestinal microbiota sequencing, measures to assess morphological characteristics (body height, body weight, triceps skinfold, subscapular skinfold, chest skinfold, abdomen skinfold, suprailiocristal skinfold, thigh skinfold, axillary skinfold, fat percentage calculated by the seven skinfolds algorithm).
Dietary methods will be used to control eating habits and fiber intake prior to testing and to control diet during testing. The methods will be a food diary (three-day) and as an unannounced control of daily food intake once a week will be a 24-hour dietary recalls. The three-day food diary will show diet and average fiber intake just before the start of testing and unannounced control of daily food intake as evidence of unchanged eating habits during the study. All collected dietary data will be processed using Croatian food tables in addition to American tables for all foods whose chemical composition is not available in national tables.
In assessing the athletic performance of basketball players, emphasis will be placed on the explosive power of the lower extremities (concentric and eccentric contractions). Anthropometric methods will use tests to assess vertical explosive power (squat jump, countermovement jump, one legged countermovement jump, maximal countermovement jump, continuous jumps with straight egs, continuous jump with bent legs) with Optojump system and explosive power - sprint (5m, 10m and 20m sprint) with the Powertimer Newtest system. Aerobic endurance tests (BEEP test with sound signal) and anaerobic endurance test (300 m (15x20)) with Powertimer Newtest system will be used to assess cardiovascular endurance. Laboratory measurements will be performed within the Sports Diagnostic Center of the Faculty of Kinesiology, University of Zagreb.
Fecal samples will be collected at the Faculty of Food Technology and Biotechnology, University of Zagreb. Analysis of the composition of the intestinal microbiota by DNA sequencing from fecal samples will be performed using an Illumina NGS device.
Participants will complete a questionnaire on a daily basis in subjective feeling of fatigue on a scale of 1 to 10 (rate of perceived exertion).
Participants will have a daily short questionnaire on: bloating, change in stool consistency, nausea and weakness.
Research plan:
The research lasts a total of 8 weeks. Initial measurements before the start of supplementation include anthropometric testing and taking the first microbiota sample. This is followed by taking another microbiota sample 2 weeks after the start of supplementation. Final measurements follow at the end of 4 weeks of supplementation that include anthropometric testing and taking a third microbiota sample. Finally, the fourth microbiota sample will be 4 weeks after the final and 8 weeks after the initial measurements, respectively. After getting acquainted with the basics of testing, participants will sign a consent to participate.
Three days before the initial testing, participants will be explained how collect feces and the collection containers will be distributed. Each participant will be subjected to a dietary method of measuring food intake, a three-day diet diary and unannounced controls of daily food intake, once a week. Initial measurements will begin by collecting fecal-sampled containers. After measuring the morphological characteristics, tests to assess explosive power and aerobic and anaerobic capacities will be approached. After the initial testing, during the regular competition season, the participants of both groups will continue the training process without the possibility of additional training or changes in the training process. The experimental group (n = 7) will consume 2x8.5 g/day of soluble dietary fiber over four weeks, while the control group (n = 7) will consume the same amount of placebo carbohydrates. The dose was determined by previous studies with a proven effect on the morphological characteristics of participants and without side effects.
Participants will be taken by the respondents after the training in the presence of the research leader, and on the day off they will send a picture of an empty bag in mobile phone application. This will resolve "compliance." The training process will be the same for both groups, and participants will be advised not to change their diet pattern for two weeks prior to the test as well as for the duration of the experiment. After each training session and basketball game, respondents will complete a questionnaire in subjective feeling of fatigue on a scale of 1 to 10 (rate of perceived exertion). The final measurements are equal to the initial ones.
Data processing methods:
The sample size in the study was estimated through a test power of 70 % and a significance level of 5 %. The statistical program SPSS (Statistical Package for the Social Science), version 17.0., SPSS, Inc. will be used for data processing. Descriptive statistical parameters of the monitored variables will be calculated: arithmetic mean (AS), standard deviation (SD), minimum (MIN), maximum (MAX) and range result (RAS) and curvature (KURT) and distribution asymmetry (SKEW), and normality distribution by the Kolmogorov-Smirnov test. Multivariate and univariate analysis of variance (MANOVA and ANOVA) will be used to analyze the effects of training between initial and final measurements within groups, as well as to analyze differences in effects between groups. In case of statistically significant differences between groups, Tukey post hoc analysis will be used to determine the difference between specific groups. All conclusions will be drawn at the level of statistical error p <0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zagreb, Croatia, 10000
- Faculty of Food Technology and Biotechnology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Professional basketball players from the same team participating in the same monitored training process
Exclusion Criteria:
- Diabetes or other chronic disease, taking sports performance enhancing drugs, taking antibiotics 3 months prior or during the course of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Experimental group
Seven randomly selected active basketball players will be supplemented with defined prebiotic fibre (20 grams per day divided in two 10 gram doses - 85% total fiber content) for the total duration of 4 weeks, while being stationed in the training camp under constant coach and nutrition expert surveillance.
|
14 adult professional baskeyball players will be divided randomly in two groups, each containing 7 players.
One group shall receive Nutriose fiber, two times per day 10 grams per dose in total duration of 4 weeks.
Second group shall receive same amount of Placebo in form of Maltodextrin.
Each group will undergo a series of sports performance tests and questionnaires and shall donate their feces several times during the study in order to monitor gut microbiota changes.
The Nutriose group in this particular intervention contains 7 randomy selected players.
Other Names:
|
PLACEBO_COMPARATOR: Control group
Seven randomly selected active basketball players will be supplemented with placebo resembling prebiotic fibre in all visible and taste aspects (20 grams per day divided in two 10 gram doses) for the total duration of 4 weeks, while being stationed in the training camp under constant coach and nutrition expert surveillance.
|
14 adult professional baskeyball players will be divided randomly in two groups, each containing 7 players.
One group shall receive Nutriose fiber, two times per day 10 grams per dose in total duration of 4 weeks.
Second group shall receive same amount of Placebo in form of Maltodextrin.
Each group will undergo a series of sports performance tests and questionnaires and shall donate their feces several times during the study in order to monitor gut microbiota changes.
This second (Placebo) group also consists of the 7 players and receives Maltodextrin supplementation.
Since the study type is "double-blind", neither the participants (players) nor the person handing out the supplementation know the exact nature of fiber substance being handed during the entire duration of the trial.
Independent statistician is handling the randomization of both interventions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rapid microbiota change
Time Frame: 2 weeks
|
The impact of fiber supplementation on gut microbiome shall assessed through monitoring of relative taxonomic abundance of bacteria that compose gut microbiota.
DNA shall be extracted from collected faecal samples, stored at -80°C.
DNA extraction shall be performed using the QIAamp® PowerFecal® DNA Kit.
DNA concentration shall be quantified using Promega Quantus Flourometer before being sent to amplicon sequencing of variable regions 3 and 4 of the 16S rRNA gene with the primer set 341F (5'-CCTAYGGGRBGCASCAG -3') 806R (5'- GGACTACNNGGGTATCTAAT -3').
Obtained sequenceing raw data (reads) shall be analyzed using 'Quantitative Insights Into Microbial Ecology 2' (QIIME2) software in order to evaluate microbial composition of each sample.
The comparison on intial sample (before intervention) and sample 1 (after 2 weeks) of supplementation shall provide a baseline insight into eventual rapid microbiota change as a response to supplementation/placebo.
|
2 weeks
|
Altered microbiota composition
Time Frame: 4 weeks
|
Prolonged supplementation after initial 2 weeks will support the established altered gut microbiota in participants receiving fiber supplement.
The impact of fiber supplementation on gut microbiome shall assessed through monitoring of relative taxonomic abundance of bacteria that compose gut microbiota.
Gut microbiota DNA shall be extracted from collected faecal samples, stored at -80°C.
DNA shall be processed in the same manner as previously described (Outcome 1).
Obtained sequenceing raw data (reads) shall be analyzed using 'Quantitative Insights Into Microbial Ecology 2' (QIIME2) software in order to evaluate microbial composition of each sample.
The comparison on intial sample (before intervention) and sample 2 (after 4 weeks) of supplementation shall provide an insight into eventual microbiota change as a response to prolonged supplementation/placebo.
|
4 weeks
|
Effect on the perception of fatigue
Time Frame: 4 weeks
|
The major question is whether the moderately increasing fiber intake in athletes has the potential to support the intestinal microbiota and conversely positively impact training-induced perception of fatigue.
In order to understand the impact of fiber consumption on the perception of fatigue, after each training session or match, the participants shall be asked to record and send a rating of perceived exertion through a mobile messaging application.
The Borg's CR10 RPE scale shall be used for this purpose.
This scale has a range from 0 to 10 (RPE - Rating of Perceived Exertion).
The RPE scale is a tool used to monitor the perceptual response to training, as a method of determining physical exertion during exercise.
The original RPE scale, developed more than 40 years ago, was primarily used to monitor aerobic load, but it still remains widely used in athlete tracking.
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long-term microbiota impact
Time Frame: 8 weeks
|
After total of 8 weeks fiber supplementation, one additional microbiota composition measurement (16S rRNA sequencing of donated fecal samples after 8 weeks of trial) will be taken after additional 4 weeks with no supplementation (intervention), in order to determine if the initial microbiota change caused by fiber supplementation can persist without additional fiber supplementation and to assess the potential for a long-term induced microbiota change.
The comparison on intial sample (before intervention), sample 1 (after 2 weeks) of supplementation and sample 2 (after 4 weeks) with sample 3 (after 8 weeks) shall provide a baseline insight into microbiota change as a response to supplementation/placebo.
DNA extraction and data processing shall be the same as in previous outcomes.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Antonio Starcevic, PhD, University of Zagreb, Faculty of Food Technology and Biotechnology
Publications and helpful links
General Publications
- Wosinska L, Cotter PD, O'Sullivan O, Guinane C. The Potential Impact of Probiotics on the Gut Microbiome of Athletes. Nutrients. 2019 Sep 21;11(10):2270. doi: 10.3390/nu11102270.
- Marttinen M, Ala-Jaakkola R, Laitila A, Lehtinen MJ. Gut Microbiota, Probiotics and Physical Performance in Athletes and Physically Active Individuals. Nutrients. 2020 Sep 25;12(10):2936. doi: 10.3390/nu12102936.
- Clark A, Mach N. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. J Int Soc Sports Nutr. 2016 Nov 24;13:43. doi: 10.1186/s12970-016-0155-6. eCollection 2016.
- Mohr AE, Jager R, Carpenter KC, Kerksick CM, Purpura M, Townsend JR, West NP, Black K, Gleeson M, Pyne DB, Wells SD, Arent SM, Kreider RB, Campbell BI, Bannock L, Scheiman J, Wissent CJ, Pane M, Kalman DS, Pugh JN, Ortega-Santos CP, Ter Haar JA, Arciero PJ, Antonio J. The athletic gut microbiota. J Int Soc Sports Nutr. 2020 May 12;17(1):24. doi: 10.1186/s12970-020-00353-w.
- Erdogan Z, Erdogan S, Aslantas O, Celik S. Effects of dietary supplementation of synbiotics and phytobiotics on performance, caecal coliform population and some oxidant/antioxidant parameters of broilers. J Anim Physiol Anim Nutr (Berl). 2010 Oct;94(5):e40-8. doi: 10.1111/j.1439-0396.2009.00973.x.
- Lefranc-Millot C, Guerin-Deremaux L, Wils D, Neut C, Miller LE, Saniez-Degrave MH. Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE(R), a soluble fibre with prebiotic properties, may be beneficial for health. J Int Med Res. 2012;40(1):211-24. doi: 10.1177/147323001204000122.
- Farhangi MA, Javid AZ, Sarmadi B, Karimi P, Dehghan P. A randomized controlled trial on the efficacy of resistant dextrin, as functional food, in women with type 2 diabetes: Targeting the hypothalamic-pituitary-adrenal axis and immune system. Clin Nutr. 2018 Aug;37(4):1216-1223. doi: 10.1016/j.clnu.2017.06.005. Epub 2017 Jun 10.
- Aliasgharzadeh A, Dehghan P, Gargari BP, Asghari-Jafarabadi M. Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes: a randomised controlled clinical trial. Br J Nutr. 2015 Jan 28;113(2):321-30. doi: 10.1017/S0007114514003675.
- Li S, Guerin-Deremaux L, Pochat M, Wils D, Reifer C, Miller LE. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl Physiol Nutr Metab. 2010 Dec;35(6):773-82. doi: 10.1139/H10-074.
- Guerin-Deremaux L, Pochat M, Reifer C, Wils D, Cho S, Miller LE. The soluble fiber NUTRIOSE induces a dose-dependent beneficial impact on satiety over time in humans. Nutr Res. 2011 Sep;31(9):665-72. doi: 10.1016/j.nutres.2011.09.004.
- Nazare JA, Sauvinet V, Normand S, Guerin-Deremaux L, Gabert L, Desage M, Wils D, Laville M. Impact of a resistant dextrin with a prolonged oxidation pattern on day-long ghrelin profile. J Am Coll Nutr. 2011 Feb;30(1):63-72. doi: 10.1080/07315724.2011.10719945.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IP-2016-06-3509
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microbiota
-
Microbio Co LtdCompleted
-
University of California, Los AngelesCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompleted
-
Afyonkarahisar Health Sciences UniversityNot yet recruiting
-
Third Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Hadassah Medical OrganizationBar-Ilan University, IsraelWithdrawn
-
Manchester University NHS Foundation TrustUniversity of ManchesterRecruiting
-
University of ManitobaAlmond Board of CaliforniaTerminated
-
Kimberly-Clark CorporationWithdrawn
-
Samara State Medical UniversityRecruitingOral MicrobiotaRussian Federation
Clinical Trials on Soluble dietary fiber with prebiotic properties
-
Children's Memorial Health Institute, PolandJan Dlugosz University in Czestochowa; Tymbark MWS Sp. with o.o. Sp. K., Poland and other collaboratorsRecruitingHypertension | NAFLD | Overweight and Obesity | Child ObesityPoland
-
Jinling Hospital, ChinaTerminated
-
Institute of Biomedical Technologies-National Research...IRCCS Eugenio Medea; Istituto Nazionale di Ricovero e Cura per Anziani; Fondazione...Completed
-
San Francisco Veterans Affairs Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Completed
-
Arizona State UniversityFrieslandCampinaCompleted
-
University of MinnesotaNestléCompleted
-
Nanjing PLA General HospitalCompletedConstipation | Hypomotility
-
Jinling Hospital, ChinaUnknownSlow Transit ConstipationChina
-
University of Illinois at Urbana-ChampaignCompleted
-
Tate & LyleBiofortis Innovation ServicesCompletedGastrointestinal ToleranceUnited States